Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Overview

The project titled "Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy" aims to address the pressing need for more effective and targeted treatment options for cancer patients. Cancer remains a significant global health challenge, with traditional chemotherapy often leading to severe side effects due to its non-specific nature. Targeted drug delivery systems offer a promising approach to improve the efficacy of cancer treatment while minimizing adverse effects on healthy tissues. This research project will focus on the development and evaluation of innovative drug delivery systems designed to specifically target cancer cells. By encapsulating anti-cancer drugs within specialized carriers, such as nanoparticles or liposomes, these systems can enhance drug accumulation at the tumor site while reducing systemic exposure. This targeted approach not only improves the therapeutic outcome but also reduces the likelihood of drug resistance development. The project will begin with a comprehensive literature review to provide a thorough understanding of existing drug delivery systems and their applications in cancer therapy. This review will encompass various aspects, including the principles of targeted drug delivery, the challenges associated with current treatment modalities, and recent advancements in the field. Subsequently, the research methodology will involve the design, synthesis, and characterization of novel drug delivery systems tailored for specific types of cancer. The evaluation of these systems will include in vitro studies to assess their drug loading capacity, release kinetics, and cytotoxicity against cancer cell lines. Promising formulations will then proceed to in vivo studies using animal models to investigate their pharmacokinetics, biodistribution, and therapeutic efficacy. The findings obtained from these experiments will be critically analyzed and discussed in detail in Chapter Four of the thesis. The discussion will highlight the strengths and limitations of the developed drug delivery systems, as well as their potential clinical implications. Moreover, comparisons with existing approaches and future directions for research will be explored to provide a comprehensive understanding of the project outcomes. In conclusion, this research project on the development and evaluation of novel drug delivery systems for targeted cancer therapy holds significant promise in advancing the field of oncology. By harnessing the potential of precision medicine and nanotechnology, the project aims to contribute to the development of safer, more efficient, and personalized treatment strategies for cancer patients.